Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Article: Engaging patient advocacy groups
- The key to conducting effective rare disease research
Research Partnership
- Webcast: Harnessing the power of social: How to generate fresh insights for your business using social media listening
Research Partnership
- Article: Like, Like, Like: Harnessing the power of social media insights
Research Partnership
- Infographic: China: How to keep up and win in the world's fastest changing healthcare market
Research Partnership
- Article: New Hopes for Mexico: What will be the future of healthcare under the country's new administration?
Research Partnership
- Event: Richard Head presented with MR Excellence award at EphMRA Conference
Research Partnership
